デフォルト表紙
市場調査レポート
商品コード
1439313

頭蓋・耳介電気治療刺激装置の世界市場:洞察、競合情勢、市場予測:2030年

Cranial & Auricular Electrotherapy Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
頭蓋・耳介電気治療刺激装置の世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の頭蓋・耳介電気治療刺激装置の市場規模は、2024年~2030年の予測期間中にCAGR 6.2%で成長すると予測されています。頭蓋・耳介電気治療刺激装置に対する需要の増加は、主に様々な精神・精神疾患の有病率の上昇、世界中の慢性疼痛症例の増加、人口間の不眠症の増加によるものです。さらに、主なメーカーによる研究開発投資の増加や、機器開発のためのさまざまな臨床試験の進行も、頭蓋・耳介電気治療刺激装置の市場を押し上げると予想されるその他の要因です。

頭蓋・耳介電気治療刺激装置は、不安、うつ、痛みなどの治療のために脳と頭蓋を活性化する4mA未満の電流を使用する小型装置です。うつ病、双極性障害、統合失調症、認知症、その他の精神病などの精神障害の有病率の増加は、頭蓋・耳介電気治療刺激装置の需要を急増させると予想されています。世界保健機関(WHO)の2019年報告によると、約2億6,400万人がうつ病に罹患しており、これは一般的な精神障害の1つであり、また世界の障害の主な原因でもあります。

さらに、人口の間で慢性疼痛の有病率が増加していることも、頭蓋・耳介電気治療刺激装置市場の促進要因となっています。例えば、米国疾病予防管理センター(CDC)の2019年のデータによると、成人人口の約20.4%が慢性疼痛に苦しんでおり、成人の少なくとも7.4%が影響の大きい慢性疼痛(生活や仕事の活動を頻繁に制限する慢性疼痛)を抱えています。

したがって、上記の要因は、世界の頭蓋・耳介電気治療刺激装置市場の潜在的な促進要因となる可能性があります。

当レポートでは、世界の頭蓋・耳介電気治療刺激装置市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 頭蓋・耳介電気治療刺激装置レポートのイントロダクション

第2章 頭蓋・耳介電気治療刺激装置のエグゼクティブサマリー

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本

第4章 頭蓋・耳介電気治療刺激装置市場の主な要因分析

  • 頭蓋・耳介電気治療刺激装置市場の促進要因
  • 頭蓋・耳介電気治療刺激装置市場の抑制要因と課題
  • 頭蓋・耳介電気治療刺激装置市場の機会

第5章 頭蓋・耳介電気治療刺激装置におけるポーターのファイブフォース分析

第6章 頭蓋・耳介電気治療刺激装置市場に対するCOVID-19の影響分析

第7章 頭蓋・耳介電気治療刺激装置市場概要

  • 製品タイプ別
  • 用途別
  • 地域別

第8章 頭蓋・耳介電気治療刺激装置の世界企業シェア分析-主要3~5社

第9章 頭蓋・耳介電気治療刺激装置の企業および製品プロファイル

  • DyAnsys Inc
  • Neuro-Fitness LLC
  • Electromedical Products International, Inc.
  • INNOVATIVE NEUROLOGICAL DEVICES
  • Fisher Wallace
  • Johari Digital
  • SzeleSTIM GmbH
  • Soterix Medical Inc
  • Brainbox Ltd
  • neurocare group AG
  • Parasym Ltd
  • Neuroelectrics
  • Masimo
  • Innovative Health Solutions INC
  • Biegler GmbH
  • Ybrain, INC
  • NEUROSANTE
  • Cefaly

第10章 プロジェクトのアプローチ

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Cranial & Auricular Electrotherapy Stimulation Devices Market
  • Table 3: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Global (2021-2030)
  • Table 4: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Global by Application (2021-2030)
  • Table 6: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Global by Geography (2021-2030)
  • Table 7: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in North America (2021-2030)
  • Table 8: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in North America by Product Type (2021-2030)
  • Table 9: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in North America by Application (2021-2030)
  • Table 10: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in North America by Country (2021-2030)
  • Table 11: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in the US (2021-2030)
  • Table 12: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Canada (2021-2030)
  • Table 13: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Mexico (2021-2030)
  • Table 14: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Europe (2021-2030)
  • Table 15: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Europe by Product Type (2021-2030)
  • Table 16: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Europe by Application (2021-2030)
  • Table 17: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Europe by Country (2021-2030)
  • Table 18: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in France (2021-2030)
  • Table 19: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Germany (2021-2030)
  • Table 20: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in the UK (2021-2030)
  • Table 21: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Italy (2021-2030)
  • Table 22: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Spain (2021-2030)
  • Table 23: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Russia (2021-2030)
  • Table 24: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 25: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 26: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 27: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Asia-Pacific by Application (2021-2030)
  • Table 28: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 29: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in China (2021-2030)
  • Table 30: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Japan (2021-2030)
  • Table 31: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in India (2021-2030)
  • Table 32: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Australia (2021-2030)
  • Table 33: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in South Korea (2021-2030)
  • Table 34: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 35: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of World (2021-2030)
  • Table 36: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 37: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of World by Application (2021-2030)
  • Table 38: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of World by Country (2021-2030)
  • Table 39: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in the Middle East (2021-2030)
  • Table 40: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Africa (2021-2030)
  • Table 41: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Cranial & Auricular Electrotherapy Stimulation Devices Market
  • Figure 3: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Global (2021-2030)
  • Figure 4: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Global by Application (2021-2030)
  • Figure 6: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 7: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in North America (2021-2030)
  • Figure 8: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in North America by Product Type (2021-2030)
  • Figure 9: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in North America by Application (2021-2030)
  • Figure 10: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in North America by Country (2021-2030)
  • Figure 11: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in the US (2021-2030)
  • Figure 12: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Canada (2021-2030)
  • Figure 13: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Mexico (2021-2030)
  • Figure 14: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Europe (2021-2030)
  • Figure 15: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Europe by Product Type (2021-2030)
  • Figure 16: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Europe by Application (2021-2030)
  • Figure 17: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 18: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in France (2021-2030)
  • Figure 19: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Germany (2021-2030)
  • Figure 20: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in the UK (2021-2030)
  • Figure 21: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Italy (2021-2030)
  • Figure 22: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Spain (2021-2030)
  • Figure 23: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Russia (2021-2030)
  • Figure 24: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 25: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 26: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 27: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Asia-Pacific by Application (2021-2030)
  • Figure 28: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 29: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in China (2021-2030)
  • Figure 30: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Japan (2021-2030)
  • Figure 31: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in India (2021-2030)
  • Figure 32: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Australia (2021-2030)
  • Figure 33: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in South Korea (2021-2030)
  • Figure 34: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 35: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of World (2021-2030)
  • Figure 36: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 37: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of World by Application (2021-2030)
  • Figure 38: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Rest of World by Country (2021-2030)
  • Figure 39: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in the Middle East (2021-2030)
  • Figure 40: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in Africa (2021-2030)
  • Figure 41: Cranial & Auricular Electrotherapy Stimulation Devices Market Analysis in South America (2021-2030)
  • Figure 42: Market Drivers
  • Figure 43: Market Barriers
  • Figure 44: Market Opportunities
  • Figure 45: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0104

Cranial & Auricular Electrotherapy Stimulation Devices Market By Product Type (Cranial Electrostimulation Devices And Auricular Electrostimulation Devices), By Application (Insomnia, Depression, Anxiety, Pain Management, And Others), By Geography is projected to expand at a significant CAGR forecast till 2030 owing to rising prevalence of mental & psychiatric disorders and growing demand for electrostimulation devices as an alternative option for treatment.

Global Cranial & Auricular Electrotherapy Stimulation Devices Market will grow at a CAGR of 6.2% during the forecast period of 2024-2030. The rise in demand for Cranial & Auricular Electrotherapy Stimulation Devices is primarily due to the rising prevalence of various mental and psychiatric disorders, increase in chronic pain cases across the globe, increasing insomnia among the population. Moreover, the rise in research and development investment by key manufacturers along with various ongoing clinical trials for device development are other factors expected to boost the market for cranial & auricular electrotherapy stimulation devices.

Cranial & Auricular Electrotherapy Stimulation Devices Market Dynamics:

Cranial and auricular electrotherapy devices are small devices that use a current of less than 4 mA for activating the brain and cranium for the treatment of anxiety, depression, pain, and others. The growing prevalence of mental disorders such as depression, bipolar disorder, schizophrenia, dementia, and other psychoses is expected to surge the demand for cranial and auricular electrotherapy stimulation devices. According to the World Health Organization (WHO) 2019 report, approximately 264 million people were affected by depression which is one of the common mental disorders and also the leading cause of disability worldwide.

In addition, the increasing prevalence of chronic pain among the population is also a driving factor for the cranial & auricular electrotherapy stimulation devices market. For instance, as per the Center for Disease Control and Prevention (CDC) 2019 data, approximately 20.4% of the adult population suffered from chronic pain and at least 7.4% of adults had high impact chronic pain (chronic pain that frequently limits life or work activities).

Thus, the above-mentioned factors could be potential driving factors for the global cranial & auricular electrotherapy stimulation devices market

However, the high cost of the cranial & auricular electrotherapy stimulation devices and lack of awareness regarding these devices may pose a minor hurdle for the growth of the Cranial & Auricular Electrotherapy Stimulation Devices market.

Cranial & Auricular Electrotherapy Stimulation Devices Segment Analysis:

Cranial & Auricular Electrotherapy Stimulation Devices Market By Product Type (Cranial Electrostimulation Devices and Auricular Electro-Stimulation Devices), By Application (Insomnia, Depression, Anxiety, Pain Management, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Cranial & Auricular Electrotherapy Stimulation Devices product segment, Cranial Stimulation Devices is anticipated to hold the largest market during the forthcoming years. This is owing to the rising research and development, and ongoing clinical trials for the development of devices for extended indications such as post-traumatic stress disorder, major depressive disorder, drug abuse, among others. For instance, Electromedical Products International, Inc. has initiated a clinical trial in the year 2017 to study the efficacy of cranial electrotherapy stimulation for the treatment of the major depressive disorder. The study is expected to complete in the year 2023.

Moreover, significant product approvals in the devices portfolio are also anticipated to spur the market. For instance, DyAnsys, Inc. received FDA approval for Drug Relief, a percutaneous nerve field stimulator system indicated to treat opioid withdrawal symptoms by electrically stimulating the cranial nerves.

In addition, rising substance use disorder could also be a potential driving factor for the cranial and auricular electrotherapy stimulation devices market growth. According to the United Nations Office on Drugs and Crime (UNODC) 2020 report, an estimated 269 million used drugs worldwide in 2018 and over 35 million people suffered from drug abuse disorders.

North America is expected to dominate the overall Cranial & Auricular Electrotherapy Stimulation Devices Market:

Among all the countries, North America is expected to dominate the overall Cranial & Auricular Electrotherapy Stimulation Devices market during the forecast period. This domination is due to the rising government initiatives to spread awareness regarding mental health disorders, sleeping disorders, and others. In addition, the presence of an advanced healthcare system is also likely to augment the market for cranial & auricular electrotherapy stimulation devices in the region

Further, in the United States, the rising cases of anxiety among the population could also contribute to the demand for cranial and auricular electrotherapy stimulation devices. For instance, as per the 2022 data of The Anxiety and Depression Association of America (ADAA), an international nonprofit organization approximately 6.8 million of the US population are affected with generalized anxiety disorder, and around 15 million of the population are affected by social anxiety disorder.

Moreover, reclassification of cranial electrotherapy stimulator devices intended to treat anxiety and/or insomnia from class III to Class II medical devices by the US Food and Drug Administration in the year 2019 could also bolster the market for cranial & auricular electrotherapy stimulation devices in the region.

In addition, the rising incidence of stress among the population of Canada is also anticipated to augment the market for these devices. For instance, as per the report of the Statistic Canada 2022, there approximately 6,560,500 population of age 12 years and above were suffering from stress in the year 2020. Thus, these factors will contribute to the market growth of cranial and auricular electrotherapy stimulation devices in the region.

Also, the Asia-Pacific region has the future potential growth for the Global Cranial & Auricular Electrotherapy Stimulation Devices. The presence of various NGOs and rising government initiatives to raise awareness regarding mental disorders is projected to augment the demand for these devices in the region. For instance, the Government of India launched the National Mental Health Programme (NMHP) in 1982 which has recently passed the Mental Health Care Act 2017 which came into force from July 07, 2018, mainly focused on treatment, rehabilitation, and raising awareness regarding the mental health disorder.

Furthermore, rising disposable income, improving healthcare facilities, and the increasing population suffering from mental disorders will contribute to the cranial and auricular electrotherapy stimulation devices market growth. According to the Australian Bureau of Statistics (ABS) National Survey of Mental Health and Wellbeing (NSMHWB) 2019 data, approximately 4.8 million Australians were suffering from a mental or behavioral condition in the year between 2017 to 2018.

Hence, all the aforementioned factors will provide lucrative opportunities for the market growth of cranial & auricular electrotherapy Stimulation devices in the region during the forecasted period.

Cranial & Auricular Electrotherapy Stimulation Devices Market Key Players:

Some of the key market players operating in the Cranial & Auricular Electrotherapy Stimulation Devices market include DyAnsys Inc, Neuro-Fitness LLC, Electromedical Products International, Inc., INNOVATIVE NEUROLOGICAL DEVICES, Fisher Wallace, Johari Digital, SzeleSTIM GmbH, Soterix Medical Inc, Brainbox Ltd, neurocare group AG, Parasym Ltd, Neuroelectrics, Masimo, Innovative Health Solutions INC, Biegler GmbH, Ybrain, INC, NEUROSANTE, Cefaly, and others.

Recent Developmental Activities in the Cranial & Auricular Electrotherapy Stimulation Devices Market:

In March 2019, Innovative Neurological Devices LLC received FDA approval for Cervella Cranial Electrotherapy Stimulator (CES) indicated for the treatment of insomnia, depression, or anxiety.

Key Takeaways from the Cranial & Auricular Electrotherapy Stimulation Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Cranial & Auricular Electrotherapy Stimulation Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Cranial & Auricular Electrotherapy Stimulation Devices Market.

Various opportunities available for the other competitor in the Cranial & Auricular Electrotherapy Stimulation Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Cranial & Auricular Electrotherapy Stimulation Devices market growth in the coming future?

Target Audience who can be benefited from the Cranial & Auricular Electrotherapy Stimulation Devices Market Report Study

Cranial & Auricular Electrotherapy Stimulation Devices providers

Research organizations and consulting companies

Cranial & Auricular Electrotherapy Stimulation Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Cranial & Auricular Electrotherapy Stimulation Devices

Various End-users who want to know more about the Cranial & Auricular Electrotherapy Stimulation Devices Market and the latest technological developments in the Cranial & Auricular Electrotherapy Stimulation Devices market.

Frequently Asked Questions for the Cranial & Auricular Electrotherapy Stimulation Devices Market:

1. What are Cranial & Auricular Electrotherapy Stimulation Devices?

Cranial & Auricular Electrotherapy Stimulation Devices are the devices that deliver weak electrical pulses to the scalp or ear lobes for treating various diseases such as chronic pain, depression, anxiety among others.

2. What is the market for Global Cranial & Auricular Electrotherapy Stimulation Devices?

Global Cranial & Auricular Electrotherapy Stimulation Devices Market will grow at a CAGR of 6.2% during the forecast period of 2024-2030.

3. What are the drivers for Global Cranial & Auricular Electrotherapy Stimulation Devices?

The major factors driving the demand for Cranial & Auricular Electrotherapy Stimulation Devices are the growing prevalence of various mental health and psychotic disorder such as depression, anxiety, stress, among others, increase in insomnia cases, and growing prevalence of chronic pain. Moreover, an increase in research and development is also likely to propel the cranial and auricular electrotherapy stimulation market.

4. What are the key players operating in Global Cranial & Auricular Electrotherapy Stimulation Devices?

Some of the key market players operating in the Cranial & Auricular Electrotherapy Stimulation Devices market include DyAnsys Inc, Neuro-Fitness LLC, Electromedical Products International, Inc., INNOVATIVE NEUROLOGICAL DEVICES, Fisher Wallace, Johari Digital, SzeleSTIM GmbH, Soterix Medical Inc, Brainbox Ltd, neurocare group AG, Parasym Ltd, Neuroelectrics, Masimo, Innovative Health Solutions INC, Biegler GmbH, Ybrain, INC , NEUROSANTE , Cefaly, and others.

5. Which region has the highest share in the Cranial & Auricular Electrotherapy Stimulation Devices Market?

North America is expected to dominate the overall Cranial & Auricular Electrotherapy Stimulation Devices market during the forecast period. This domination is due to the rising government initiatives to spread awareness regarding mental health disorders, sleeping disorders, and others. In addition, the presence of an advanced healthcare system is also likely to augment the market for cranial & auricular electrotherapy stimulation devices in the region.

Table of Contents

1. Cranial & Auricular Electrotherapy Stimulation Devices Report Introduction

2. Cranial & Auricular Electrotherapy Stimulation Devices Executive summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
    • 3.2.1. Germany
    • 3.2.2. France
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. The U.K.
  • 3.3. Japan

4. Cranial & Auricular Electrotherapy Stimulation Devices Market Key factors analysis

  • 4.1. Cranial & Auricular Electrotherapy Stimulation Devices Market Drivers
    • 4.1.1. The rise in prevalence of mental health disorders
    • 4.1.2. Increase in the cases of insomnia
    • 4.1.3. Growing Research and development & ongoing clinical trials
    • 4.1.4. Product approval
  • 4.2. Cranial & Auricular Electrotherapy Stimulation Devices Market Restraints and Challenges
    • 4.2.1. Lack of reimbursement
    • 4.2.2. High cost of the devices
  • 4.3. Cranial & Auricular Electrotherapy Stimulation Devices Market Opportunities
    • 4.3.1. Growth opportunities among low-income countries
    • 4.3.2. Rising government initiatives to raise awareness among the target population

5. Cranial & Auricular Electrotherapy Stimulation Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Cranial & Auricular Electrotherapy Stimulation Devices Market

7. Cranial & Auricular Electrotherapy Stimulation Devices Market layout

  • 7.1. By Product Type
    • 7.1.1. Cranial Electrostimulation Devices
    • 7.1.2. Auricular Electro stimulation Devices
  • 7.2. By Application
    • 7.2.1. Insomnia
    • 7.2.2. Depression
    • 7.2.3. Anxiety
    • 7.2.4. Pain management
    • 7.2.5. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. North America Cranial & Auricular Electrotherapy Stimulation Devices Market, by Product Type
      • 7.3.1.2. North America Cranial & Auricular Electrotherapy Stimulation Devices Market, by Application
      • 7.3.1.3. North America Cranial & Auricular Electrotherapy Stimulation Devices Market, by Country
      • 7.3.1.3.1. United States
      • 7.3.1.3.2. Canada
      • 7.3.1.3.3. Mexico
    • 7.3.2. Europe
      • 7.3.2.1. Europe Cranial & Auricular Electrotherapy Stimulation Devices Market, by Product Type
      • 7.3.2.2. Europe Cranial & Auricular Electrotherapy Stimulation Devices Market, by Application
      • 7.3.2.3. Europe Cranial & Auricular Electrotherapy Stimulation Devices Market, by Country
      • 7.3.2.3.1. France
      • 7.3.2.3.2. Germany
      • 7.3.2.3.3. United Kingdom
      • 7.3.2.3.4. Italy
      • 7.3.2.3.5. Spain
      • 7.3.2.3.6. Russia
      • 7.3.2.3.7. Rest of Europe
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. Asia-Pacific Cranial & Auricular Electrotherapy Stimulation Devices Market, by Product Type
      • 7.3.3.2. Asia-Pacific Cranial & Auricular Electrotherapy Stimulation Devices Market, by Application
      • 7.3.3.3. Asia-Pacific Cranial & Auricular Electrotherapy Stimulation Devices Market, by Country
      • 7.3.3.3.1. China
      • 7.3.3.3.2. Japan
      • 7.3.3.3.3. India
      • 7.3.3.3.4. Australia
      • 7.3.3.3.5. South Korea
      • 7.3.3.3.6. Rest of Asia Pacific
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. RoW Cranial & Auricular Electrotherapy Stimulation Devices Market, by Product Type
      • 7.3.4.2. RoW Cranial & Auricular Electrotherapy Stimulation Devices Market, by Application
      • 7.3.4.3. RoW Cranial & Auricular Electrotherapy Stimulation Devices Market, by Region
      • 7.3.4.3.1. Middle East
      • 7.3.4.3.2. Africa
      • 7.3.4.3.3. South America

8. Cranial & Auricular Electrotherapy Stimulation Devices Global Company Share Analysis - Key 3-5 Companies

9. Cranial & Auricular Electrotherapy Stimulation Devices Company and Product Profiles

  • 9.1. DyAnsys Inc
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Neuro-Fitness LLC
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Electromedical Products International, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. INNOVATIVE NEUROLOGICAL DEVICES
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Fisher Wallace
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Johari Digital
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. SzeleSTIM GmbH
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Soterix Medical Inc
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Brainbox Ltd
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. neurocare group AG
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Parasym Ltd
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Neuroelectrics
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Masimo
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Innovative Health Solutions INC
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Biegler GmbH
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Ybrain, INC
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. NEUROSANTE
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Cefaly
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy

10. Project Approach

  • 10.1. Secondary Sources
  • 10.2. Primary Sources
  • 10.3. Data Triangulation
  • 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight